Altogether, 26 funds focused on pharma and healthcare collectively manage Rs 30,306 crore. Some of them offer exposure to ...

Roche recently joined naysayers who argue the deal threatens competition in the burgeoning weight loss and diabetes drug ...

The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.

Donald Trump and Robert F. Kennedy Jr.’s recent vow to tackle public health issues together signals a shift in Republican priorities.

Telix Pharmaceuticals leverages a novel theranostic approach, offering a unique risk-reward model in the challenging biotech ...

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 819% — a market-crushing outperformance compared to 170% for the S&P 500.* They just ...

Breast cancer is on the rise in Virginia, as well as the costs associated with treatment. Vance defends MSG rally; Dodgers take 3-0 lead over Yankees ...

He has gotten large donations from and owns hundreds of thousands of dollars in stocks in drug and medical device companies.

As October draws to a close, it's time to take a look at the regulatory news that made headlines in the month and look ahead to ...

As companies hire more, as jobs get generated, everybody wants to have a better place to live, better lifestyle and this is a ...

BioSpace has been compiling a list of the most innovative and exciting biotechs for a decade. Here we take a look back at ...

Hong Kong Pharma Digital Technology Holdings filed for a 1.5 million-share initial public offering. The company said Tuesday it was expecting its IPO to price between $4 and $6 per share, adding it ...